As part of the European Commission’s Innovative Medicines Initiative (IMI) program, the project “Identifying Digital Endpoints to Assess FAtigue, Sleep and ActiVities, Daily Living in Neurodegenerative Disorders and Immune-mediated inflammatory diseases”, acronym IDEA-FAST, was funded. The project was submitted by the University of Newcastle Upon Tyne, as coordinating body, to which the University of Brescia participates as a partner body, with Principal Investigator Dr. Andrea Pilotto, Department of Clinical and Experimental Sciences.
Forty-five other partners from different countries (United Kingdom, Germany, Netherlands, Ireland, France, Belgium, Spain, Portugal, Italy, Finland, Poland, Austria, Norway, Switzerland, United States) both from the academic and industrial world, participate in the project.
he total funding allocated to the projects amounts to € 344,500.00.